Morpholine

Morpholine

SCHEMBL6700992

C1COCCN1.Nc1ccc(C=O)cc1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39
TRIM24 O15164 1/20 0.36
TRIM33 Q9UPN9 1/20 0.36
ALDH1A1 P00352 5/20 0.36
ALDH3A1 P30838 1/20 0.36
ALDH1A3 P47895 1/20 0.36
TYR P14679 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP2A6 P11509 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALDH5A1 P51649 1/20 0.34
ABAT P80404 1/20 0.34
APEX1 P27695 1/20 0.33
APP P05067 1/20 0.33
CYP19A1 P11511 1/20 0.32
MAOA P21397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Morpholine SCHEMBL28439560 0.81 CYP2A6 (0.59) KDM4EMEN1KMT2AGAACYP2C9
Benzaldehyde SCHEMBL11862136 0.81 ALDH1A1 (0.56) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL28295537 0.79 EGFR (0.38) KDM4EMEN1KMT2AGAACYP2C9
Anisaldehyde SCHEMBL28293798 0.77 ALDH1A1 (0.63) KDM4EALDH1A1ALDH1A3CYP2A6
SCHEMBL28226740 0.77 CYP2A6 (0.52) KDM4EMEN1KMT2AALDH1A1ALDH3A1
SCHEMBL28553043 0.77 CYP2A6 (0.52) KDM4EMEN1KMT2AALDH1A1ALDH3A1
SCHEMBL214899 0.77
SCHEMBL28362581 0.75 CYP2A6 (0.50) KDM4EMEN1KMT2AALDH1A1ALDH3A1
Hydrochloric Acid SCHEMBL28738883 0.75 CYP2A6 (0.50) KDM4EMEN1KMT2AALDH1A1ALDH3A1
SCHEMBL27952608 0.75 CYP2A6 (0.50) KDM4EMEN1KMT2AALDH1A1ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110745-A1 Therapeutic chroman compounds INTEL CORPORATION 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110745-A1 Therapeutic chroman compounds HTR1A, ACHE, CALCA KDM4E 1843/4885MEN1 143/4885KMT2A 2838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.